Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab

Total duration:2 h 21 min

	Emerging Pharmacotherapies and Future Perspectives for Obesity Treatment	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	15:06
	ESPAÑOL: De Hígado Graso No Alcohólico (NAFLD) a Enfermedad Hepática Esteatósica Asociada a Disfunción Metabólica (MASLD)	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	10:35
	From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD), an update of the new terminology and its significance	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	20:04
	ESPAÑOL: Lo que debes saber de Obesidad: ¿Qué tan frecuente es la obesidad, cómo desarrollamos la obesidad y por qué es importante?	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	19:49
	Obesity 101: How Prevalent Is Obesity, How Do We Develop Obesity, and Why It Matters?	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	30:13
	ESPAÑOL: Enfermedad del hígado graso: una necesidad clínica no satisfecha	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	14:50
	Fatty Liver Disease: An Unmet Clinical Need	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	21:41
	Español: Introducción ¡Bienvenidos a nuestro Podcast!	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	04:44
	Introduction, Welcome To Our Podcast!	Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab	04:43